{"id":5258,"date":"2010-10-14T11:18:10","date_gmt":"2010-10-14T10:18:10","guid":{"rendered":"http:\/\/www.ethicalquote.com\/?p=5258"},"modified":"2010-10-15T11:24:25","modified_gmt":"2010-10-15T10:24:25","slug":"pledge-of-150m","status":"publish","type":"post","link":"https:\/\/www.covalence.ch\/index.php\/2010\/10\/14\/pledge-of-150m\/","title":{"rendered":"Pledge of $150m to fight neglected diseases"},"content":{"rendered":"<p><a href=\"http:\/\/www.ft.com\/cms\/s\/0\/b1895574-d7b0-11df-b478-00144feabdc0.html\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-5261\" title=\"101015_nd\" src=\"http:\/\/www.ethicalquote.com\/newTemplate\/wp-content\/uploads\/2010\/10\/101015_nd.jpg\" alt=\"\" width=\"200\" height=\"130\" \/><\/a>Six pharmaceutical companies and several governments have pledged  more than $150m in medicines and funding over five years to tackle some  of the most neglected diseases. The debilitating illnesses \u2014 including leprosy, lymphatic  filariasis and sleeping sickness \u2014 affect 1bn of the world\u2019s poorest  people, place a burden on health services, stunt children\u2019s education  and hinder economic development. (&#8230;) The companies involved are Novartis, GlaxoSmithKline, Sanofi-Aventis, Johnson &amp; Johnson, Bayer and Eisai of Japan. Image: lidc.org.uk. <a href=\"http:\/\/www.ft.com\/cms\/s\/0\/b1895574-d7b0-11df-b478-00144feabdc0.html\" target=\"_blank\">More&#8230;<\/a><\/p>\n<p>News selected by Covalence | Country: Global |  Company: Novartis, GlaxoSmithKline, Sanofi-Aventis, Johnson &amp; Johnson, Bayer, Eisai | Source: <a href=\"http:\/\/www.ft.com\/cms\/s\/0\/b1895574-d7b0-11df-b478-00144feabdc0.html\" target=\"_blank\">Financial Times<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Six pharmaceutical companies and several governments have pledged more than $150m in medicines and funding over five years to tackle some of the most neglected diseases. The debilitating illnesses \u2014 including leprosy, lymphatic filariasis and sleeping sickness \u2014 affect 1bn of the world\u2019s poorest people, place a burden on health services, stunt children\u2019s education and&hellip;<\/p>\n","protected":false},"author":665,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"wds_primary_category":0,"wds_primary_post_series":0,"footnotes":""},"categories":[1],"tags":[72,62,30,11,10],"post_series":[],"class_list":["post-5258","post","type-post","status-publish","format-standard","hentry","category-news","tag-bayer","tag-gsk","tag-jj","tag-novartis","tag-sanofi-aventis","entry","no-media"],"_links":{"self":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/5258","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/users\/665"}],"replies":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/comments?post=5258"}],"version-history":[{"count":0,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/5258\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/media?parent=5258"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/categories?post=5258"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/tags?post=5258"},{"taxonomy":"post_series","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/post_series?post=5258"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}